MedPath

Ultraxime

Brand Name: Ultraxime

Generic Name: Cefixime

Active
Registration Number

DRP-12887

Dosage Form

Granules For Suspension (Strawberry Flavor)

Issuance Date

January 31, 2024

Expiry Date

January 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/5 mL
PackagingUSP Type III Amber Bottle x 30 mL and 60 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CefiximeActive
Monograph: Cefixime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform